Pharmaceuticals, Biotechnology and Life Sciences
– BT5528 optimized to have distinct physiochemical and in vivo properties thought to enable more favorable preclinical safety, efficacy profiles…
Industry leaders connecting patient advocacy organizations in virtual approach ROCHESTER, N.Y. & PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #AdvocacyExchange–In light of the COVID-19…
Nature Biotechnology Publishes Comprehensive Description and Validation of the GeoMx Digital Spatial Profiler Using both nCounter & NGS Read Outs…
— Study met primary endpoint of time to neutrophil engraftment — — Omidubicel represents potential transformative treatment option for patients…
Te U.S. Food and Drug Administration (FDA) approved the myChoice CDx test for use as a companion diagnostic by healthcare professionals to identify certaikn advanced ovarian cancer patients.
Novavax said Monday that the Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million of additional funding, on top of $4 million it invested in March, to advance clinical development of NVX-CoV2373, Novavax’ coronavirus vaccine candidate against SARS-CoV-2.
Amryt has reported $44.6M unaudited Q1 revenues representing 30% for the first quarter ended March 31, 2020. The net loss for the period was $17.0M, compared to 2.8 in the same period last year.
Sterling Pharma has announced a partnership with Accord Healthcare to secure the UK supply chain for Hydroxychloroquine (HCQ), a medication currently under investigation for the prevention and treatment of COVID-19.
Continues to be launch ready for PALFORZIATM EU and Swiss regulatory reviews for PALFORZIA remain on schedule Uninterrupted drug supply…
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company, today announced financial results for the first quarter…